Article
Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice.
Nature - 6 Sept 2001
Krimpenfort P, Quon K C, Mooi W J, Loonstra A, Berns A
Abstract excerpt
CDKN2A (INK4a/ARF) is frequently disrupted in various types of human cancer, and germline mutations of this locus can confer susceptibility to melanoma and other tumours. However, because CDKN2A encodes two distinct cell cycle inhibitory proteins, p16INK4a and p14ARF (p19Arf in mice), the mechanism of tumour suppression by CDKN2A has remained controversial. Genetic disruption of Cdkn2a(p19Arf) (hereafter Arf)...
Topics
- 9,10-Dimethyl-1,2-benzanthracene
- Animals
- Carcinogens
- Cell Transformation, Neoplastic
- Cells, Cultured
- Cyclin-Dependent Kinase Inhibitor p16
- Embryo, Mammalian
- Female
- Fibroblasts
- Gene Deletion
- Genes, p16
